Offer - Urjas Oil for just ₹ 1 X
Ropiro 1 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Parkinson's Disease, Restless Legs Syndrome. The alternative uses of Ropiro 1 Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Ropiro 1 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Ropiro 1 Tablet include Sleepiness, Weakness, Influenza like symptoms. Some other side effects of Ropiro 1 Tablet have been listed ahead. Such side effects of Ropiro 1 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Ropiro 1 Tablet's effect during pregnancy is Moderate and Severe while nursing. In addition, Ropiro 1 Tablet's effects on the liver, heart and kidney are discussed below in the Ropiro 1 Tablet related warnings section.
Ropiro 1 Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Psychosis as it can result in adverse effects. Other conditions have been mentioned below in the Ropiro 1 Tablet contraindications section.
Additionally, Ropiro 1 Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Ropiro 1 Tablet is not safe while driving, and is is not addictive in nature.
Ropiro 1 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ropiro 1 Tablet safe for pregnant women?
Ropiro may have some side effects during pregnancy. Pregnant women should discontinue the use of Ropiro, and talk to their doctor, if they notice any discomfort.
Is the use of Ropiro 1 Tablet safe during breastfeeding?
Ropiro should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Ropiro 1 Tablet on the Kidneys?
Ropiro may have mild side effects on the kidneys.
What is the effect of Ropiro 1 Tablet on the Liver?
Ropiro is rarely harmful for the liver.
What is the effect of Ropiro 1 Tablet on the Heart?
Ropiro is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Ropiro 1 Tablet unless your doctor advises you to do so -
Is this Ropiro 1 Tablet habit forming or addictive?
Ropiro 1 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Ropiro 1 Tablet can make you feel drowsy.
Is it safe?
Yes, but take Ropiro 1 Tablet only as per medical advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Ropiro 1 Tablet can help with mental disorders.
Interaction between Food and Ropiro 1 Tablet
Taking Ropiro 1 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Ropiro 1 Tablet
Consuming Ropiro 1 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Requip (ropinirole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1114-1116